Notification No. 12/2021
Date: September 30, 2021
Subject: Temporary concessional/exempt GST rates on COVID-19 related medicines.
Description:
This notification grants Nil or 2.5% CGST on specified COVID-19 medicines such as Tocilizumab, Amphotericin-B, Remdesivir, Favipiravir, 2-Deoxy-D-Glucose, etc. The concession is time-bound and aimed at reducing treatment cost during the pandemic.
Issued for earlier notification?
No — this is a standalone temporary relief notification.
Other Notifications
16/2025
Provisions of sections 121(ii) and (iii), sections 122 to 124, and sections 126 ...
Read More06/2019
Replaces the constitutional reference for exemption threshold determination with...
Read More22/2021
The notification restricts concessional service entries under S. No. 3 to suppli...
Read More